Intravitreal injection of Bevacizumab
Sponsors
Kobe University Graduate school of Medicine, School of Medicine Toho University, Department of Ophthalmology, Shiga University of Medical Science, Asociación para Evitar la Ceguera en México, Barnes Retina Institute
Conditions
Age Related Macular DegenerationCentral Serous ChorioretinopathyChoroidal NeovascularizationDiabetic RetinopathyMacular EdemaMultifocal ChoroiditisProliferative Diabetic RetinopathyRetinal Vein Occlusion
Phase 1
Phase 2
Intravitreal Bevacizumab vs Photocoagulation for Proliferative Diabetic Retinopathy
WithdrawnNCT00347698
Start: 2006-03-31End: 2007-08-31Updated: 2024-05-30
Intravitreal Bevacizumab for the Treatment of Central Serous Chorioretinopathy
WithdrawnNCT00418431
Start: 2006-04-30End: 2006-08-31Updated: 2024-06-05
Comparison of Therapeutic Effects Between Intravitreal Injection of Bevacizumab With Intravitreal Injection of Bevacizumab and Targeted Laser Photocoagulation of Non Perfused Areas of Retina in Patients With Acute Retinal Vein Occlusion
NCT03353324
Start: 2017-11-01End: 2018-09-30Target: 74Updated: 2018-05-31
Comparison of Combined Intravitreal Bevacizumab and Oral Acetazolamide Versus Intravitreal Bevacizumab Alone for the Treatment of Macular Edema Secondary to Retinal Vein Occlusions
NCT05290948
Start: 2022-03-12End: 2022-12-01Target: 57Updated: 2022-03-22
Phase 3
Effect of Avastin in Juxtafoveal Telangiectasias
WithdrawnNCT00406380
Start: 2006-09-30End: 2006-11-30Updated: 2024-05-30
Intravitreal Bevacizumab for Inflammatory Neovascular Membranes
WithdrawnNCT00407121
Start: 2006-12-31End: 2006-12-31Updated: 2024-05-30
Efficacy of Retreatments With Intravitreal Bevacizumab
TerminatedNCT00406744
Start: 2006-05-31End: 2006-11-30Updated: 2024-06-03
Phase 4
Unknown Phase
Bevacizumab Versus Ranibizumab in Treatment of Macular Edema From Vein Occlusion
CompletedNCT01428388
Start: 2011-09-30End: 2015-12-31Target: 150Updated: 2017-10-27
Anti-vascular endothelial growth factor therapy for ocular diseases of neovascularization
Active, not recruitingJPRN-UMIN000027243
Start: 2015-07-01Target: 20Updated: 2026-06-29
The intravitreal injection of Bevacizumab for retinopathy of prematurity
Active, not recruitingJPRN-UMIN000028770
Start: 2014-09-30Target: 24Updated: 2026-06-29